• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 18 of 19
Biotech “bubble” popped, time to buy again?
FinanceBiotech “bubble” popped, time to buy again?
By Jen WiecznerMarch 27, 2015
Biotech pros’ top 8 stock picks
TechBiotech pros’ top 8 stock picks
By Jen WiecznerMarch 9, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
FeaturesFDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
Inside of a Gilead Sciences Lab
TechIs the future of pharma about making good drugs great?
By Laura LorenzettiFebruary 27, 2015
Bristol Myers
FinanceFlexus goes from zero to $1.25 billion in 17 months
By Dan PrimackFebruary 24, 2015
Third Rock Ventures: Giving birth to a new generation of biotechs
TechThird Rock Ventures: Giving birth to a new generation of biotechs
By Jennifer AlseverFebruary 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
A powerful new super antibiotic may be right under our feet
TechA powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
The $3 billion startup that wants to help you to make medicines in your own body
FinanceThe $3 billion startup that wants to help you to make medicines in your own body
By Dan PrimackJanuary 8, 2015
Davos World Economic Forum (WEF) 2011
LeadershipSean Parker gives $24 million to Stanford to cure allergies
By Jen WiecznerDecember 17, 2014
2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech
Finance2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech
By Jen Wieczner and Lauren Silva LaughlinDecember 4, 2014
Daniel Loeb urges Amgen to split into two companies
FinanceDaniel Loeb urges Amgen to split into two companies
By ReutersOctober 21, 2014
Michelle Dipp, CEO Of OvaScience
MPWOvaScience CEO talks Apple, Facebook and the $9 billion fertility market
By Matt McCueOctober 16, 2014
How to stop Ebola
FeaturesHow to stop Ebola
By Erika FrySeptember 4, 2014
Catalent delivers with $871 million biotech IPO
FinanceCatalent delivers with $871 million biotech IPO
By Laura LorenzettiJuly 31, 2014
1...
  • 15
  • 16
  • 17
  • 18
  • 19
19
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.